Medisys Technologies Inc.'s Israeli Production Facility Receives High-Speed Multi-Cavity Molds for CoverTip Safety Syringe.Health Editors BATON ROUGE Baton Rouge (băt`ən r  zh) [Fr.,=red stick], city (1990 pop. 219,531), state capital and seat of East Baton Rouge parish, SE La. , La. & FAR HILLS, N.J.--(BW HealthWire)--August 8, 2000 Medisys Technologies, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: SCEP SCEP Student Career Experience Program SCEP Simple Certificate Enrollment Protocol (Cisco) SCEP Syndicat Canadien des Communications, de l'Énergie et du Papier (Communications, Energy and Paperworkers Union) ), a pioneer in the design and development of safety needle devices, today announced that Dispomedic 2000, the Company's production facility for its safety devices, received the first of a series of high-speed multi-cavity molds for plastic injection and production of the CoverTip(TM) safety syringe. These molds will go on line later this year and will provide product components for CoverTip's market introduction this fall. Kerry M. Frey, President and COO of Medisys Technologies, Inc., commented, "This first series of molds marks the beginning for the mass production of CoverTip and its highly anticipated entry into the syringe market. We are excited that all of our research and development efforts will soon come to fruition. CoverTip technology provides healthcare workers with the safety syringes that are now mandated by 15 states, which equates to new found safety for over 100 million people of the U.S. population. Commercialization of the CoverTip provides an immediate solution to safety needle legislation which many more states are beginning to also draft to confront critical safety issues." About Medisys Technologies, Inc. Medisys Technologies, Inc. has 19 U.S. patents covering medical safety devices and other products. In addition to the CoverTip(TM) hypodermic syringe hypodermic syringe n. A syringe with a calibrated barrel, plunger, and tip, used with a hypodermic needle for hypodermic injections and for aspiration. , the Medisys portfolio of patented safety devices includes: BXDraw(TM), a fine needle biopsy/aspiration safety syringe; SofDraw(TM), a blood and fluid collection safety syringe; and MultiDraw(TM), a needleless multiple vacuum vial vial a small bottle. blood collection safety device. The Company has filed, or is filing, patent applications for new safety designs in blood collection, capillary blood testing, and tissue excision cutting needles. In total, the Company has 19 patent applications pending for its medical devices both in the U.S. and overseas. Statements in this release may be construed to be forward looking and are made pursuant to the Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Reform Act of 1995. Investors are cautioned that all forward-looking statement forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. involve risks and uncertainties, including, but not limited to, risks associated with regulatory approvals, lack of adequate capitalization and/or other risks inherent in medical device and other product development. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion